{"id":1536,"date":"2019-04-11T00:35:59","date_gmt":"2019-04-11T00:35:59","guid":{"rendered":"https:\/\/www.medicalmarijuanainc.com\/?p=130160"},"modified":"2019-04-11T00:35:59","modified_gmt":"2019-04-11T00:35:59","slug":"axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/","title":{"rendered":"AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments"},"content":{"rendered":"

Recent agreement with research organization initiates studies on potential cannabinoid treatments for drug-related psychosis and chemotherapy-related nausea in cancer and AIDS patients.<\/span><\/i><\/h3>\n

Medical Marijuana, Inc. investment <\/span>AXIM\u00ae Biotechnologies<\/span><\/a> has taken an important step toward the successful creation of cannabinoid-based treatments for a pair of medical conditions. The company has signed an agreement to begin clinical studies on a pair of leading drug candidates \u2013 MedChew\u00ae with Dronabinol and CanChew\u00ae Rx.<\/span><\/p>\n

An innovator in cannabinoid research and development, AXIM\u00ae has entered into a Services Agreement with contract research organization (\u201cCRO\u201d) QPS Netherlands BV to begin separate bio comparison studies with these two products to validate their potential as new drugs. \u00a0<\/span><\/p>\n

Both products are chewing gums containing cannabinoids and utilize the company\u2019s patented chewing gum delivery mechanism. CanChew\u00ae Rx is formulated with cannabidiol (CBD); MedChew\u00ae with Dronabinol makes use of synthetic THC.<\/span><\/p>\n

\u201cWe look forward to continuing our support for AXIM as they conduct these studies and remain optimistic about the company\u2019s positive future results,\u201d said Medical Marijuana, Inc. CEO Dr. Stuart Titus. \u201cIt is very important for us to be able to prove the efficacy and safety of our products and it is great to see that two of AXIM\u2019s developed products will be tested in these upcoming studies.\u201d<\/span><\/p>\n

QPS Netherlands BV is a respected global leader in contract research, making them a strong choice in CRO to conduct the necessary studies on AXIM\u00ae\u2019s potential new drugs \u2013 CanChew\u00ae Rx and MedChew\u00ae. <\/span><\/p>\n

\u201cReaching this agreement is an important step in our clinical development program as we work diligently on the many stages of trials to get our products to those suffering from a range of symptoms,\u201d said John Huemoeller, CEO of AXIM\u00ae Biotech. \u201cWe are proud to work with a well-respected company such as QPS Netherlands that shares our commitment to excellence to bring well-tested and proven drugs to market.\u201d<\/span><\/p>\n

MedChew\u00ae<\/span><\/h2>\n

The company will conduct two open label single dose studies that will vary chew duration and concentration to determine the best formulation and use for MedChew\u00ae. These studies will be followed by a double-blind, randomized, multiple dose study to test the bioavailability of Dronabinol in MedChew\u00ae. <\/span><\/p>\n

MedChew\u00ae formulated with Dronabinol is intended for treatment of chemotherapy-induced nausea and vomiting in cancer and AIDS patients. AXIM\u00ae intends to register the product with the FDA on the basis of a 505(b)(2) application as an improved version of an existing drug.<\/span><\/p>\n

CanChew\u00ae Rx<\/span><\/h2>\n

QPS Netherlands BV will also run an open-label, randomized, three-period crossover pharmacokinetic study on AXIM\u00ae\u2018s CanChew\u00ae Rx to study how the CBD in this product is absorbed, processed, and excreted from the body to ensure it will be effective as a treatment option. <\/span><\/p>\n

CanChew\u00ae Rx is intended to treat symptoms associated with drug-related psychosis. Drug-induced psychosis is when a psychotic episode is linked to the abuse of a drug. This can occur from taking too much of a certain drug, having an adverse reaction from a drug or after mixing substances, or withdrawal from a drug. Drug-related psychosis doesn\u2019t have to be caused by illicit drugs like cocaine and methamphetamines. Common pharmaceutical medications and even alcohol can also cause psychosis.<\/span><\/p>\n

AXIM\u00ae has developed a <\/span>method for extracting and encapsulating over 99 percent pure cannabinoids<\/span><\/a>. These high purity, microencapsulated cannabinoids are ideal for development into a variety of pharmaceutical applications, such as the creation of CanChew\u00ae RX. <\/span><\/p>\n

AXIM\u00ae\u2019s Other Areas of Research<\/span><\/h2>\n

AXIM\u00ae Biotechnologies is currently in the pre-clinical stage for cannabinoid-based new drugs for <\/span>Restless Leg Syndrome<\/span><\/a> and the pain and spasticity linked to <\/span>Multiple Sclerosis<\/span><\/a>. Both of these new drugs will take advantage of the company\u2019s patented chewing gum delivery method for cannabinoids. <\/span><\/p>\n

Learn More<\/span><\/h2>\n

Visit the Medical Marijuana, Inc. news feed for the latest from across our portfolio of investments and subsidiaries. <\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Recent agreement with research organization initiates studies on potential cannabinoid treatments for drug-related psychosis and chemotherapy-related nausea in cancer and AIDS patients. Medical Marijuana, Inc. investment AXIM\u00ae Biotechnologies has taken an important step toward the successful creation of cannabinoid-based treatments for a pair of medical conditions. The company has signed an agreement to begin clinical […]<\/p>\n","protected":false},"author":1,"featured_media":1537,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[160,3],"tags":[],"class_list":["post-1536","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-axim-biotechnologies","category-company-news"],"yoast_head":"\nAXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments - Medical Marijuana, Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments - Medical Marijuana, Inc.\" \/>\n<meta property=\"og:description\" content=\"Recent agreement with research organization initiates studies on potential cannabinoid treatments for drug-related psychosis and chemotherapy-related nausea in cancer and AIDS patients. Medical Marijuana, Inc. investment AXIM\u00ae Biotechnologies has taken an important step toward the successful creation of cannabinoid-based treatments for a pair of medical conditions. The company has signed an agreement to begin clinical […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/\" \/>\n<meta property=\"og:site_name\" content=\"Medical Marijuana, Inc.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MJNAInc\" \/>\n<meta property=\"article:published_time\" content=\"2019-04-11T00:35:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2019\/04\/mjna-blog-pipette-11-17-16-ver1-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"adminTorusBrand\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:site\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminTorusBrand\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/\"},\"author\":{\"name\":\"adminTorusBrand\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\"},\"headline\":\"AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments\",\"datePublished\":\"2019-04-11T00:35:59+00:00\",\"dateModified\":\"2019-04-11T00:35:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/\"},\"wordCount\":642,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"articleSection\":[\"Axim Biotechnologies\",\"Company News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/\",\"name\":\"AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments - Medical Marijuana, Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\"},\"datePublished\":\"2019-04-11T00:35:59+00:00\",\"dateModified\":\"2019-04-11T00:35:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medicalmarijuanainc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"name\":\"Medical Marijuana, Inc.\",\"description\":\"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!\",\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\",\"name\":\"Medical Marijuana, Inc.\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"contentUrl\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"width\":512,\"height\":512,\"caption\":\"Medical Marijuana, Inc.\"},\"image\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MJNAInc\",\"https:\/\/twitter.com\/mjna_inc\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\",\"name\":\"adminTorusBrand\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"caption\":\"adminTorusBrand\"},\"sameAs\":[\"https:\/\/medicalmarijuanainc.com\"],\"url\":\"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments - Medical Marijuana, Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/","og_locale":"en_US","og_type":"article","og_title":"AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments - Medical Marijuana, Inc.","og_description":"Recent agreement with research organization initiates studies on potential cannabinoid treatments for drug-related psychosis and chemotherapy-related nausea in cancer and AIDS patients. Medical Marijuana, Inc. investment AXIM\u00ae Biotechnologies has taken an important step toward the successful creation of cannabinoid-based treatments for a pair of medical conditions. The company has signed an agreement to begin clinical […]","og_url":"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/","og_site_name":"Medical Marijuana, Inc.","article_publisher":"https:\/\/www.facebook.com\/MJNAInc","article_published_time":"2019-04-11T00:35:59+00:00","og_image":[{"width":1200,"height":500,"url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2019\/04\/mjna-blog-pipette-11-17-16-ver1-1.png","type":"image\/png"}],"author":"adminTorusBrand","twitter_card":"summary_large_image","twitter_creator":"@mjna_inc","twitter_site":"@mjna_inc","twitter_misc":{"Written by":"adminTorusBrand","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/#article","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/"},"author":{"name":"adminTorusBrand","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c"},"headline":"AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments","datePublished":"2019-04-11T00:35:59+00:00","dateModified":"2019-04-11T00:35:59+00:00","mainEntityOfPage":{"@id":"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/"},"wordCount":642,"commentCount":0,"publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"articleSection":["Axim Biotechnologies","Company News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/","url":"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/","name":"AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments - Medical Marijuana, Inc.","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/#website"},"datePublished":"2019-04-11T00:35:59+00:00","dateModified":"2019-04-11T00:35:59+00:00","breadcrumb":{"@id":"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medicalmarijuanainc.com\/2019\/04\/11\/axim-biotechnologies-to-begin-clinical-studies-on-thc-and-cbd-chewing-gum-treatments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medicalmarijuanainc.com\/"},{"@type":"ListItem","position":2,"name":"AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments"}]},{"@type":"WebSite","@id":"https:\/\/medicalmarijuanainc.com\/#website","url":"https:\/\/medicalmarijuanainc.com\/","name":"Medical Marijuana, Inc.","description":"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!","publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medicalmarijuanainc.com\/#organization","name":"Medical Marijuana, Inc.","url":"https:\/\/medicalmarijuanainc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/","url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","contentUrl":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","width":512,"height":512,"caption":"Medical Marijuana, Inc."},"image":{"@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MJNAInc","https:\/\/twitter.com\/mjna_inc"]},{"@type":"Person","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c","name":"adminTorusBrand","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","caption":"adminTorusBrand"},"sameAs":["https:\/\/medicalmarijuanainc.com"],"url":"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/"}]}},"_links":{"self":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/1536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/comments?post=1536"}],"version-history":[{"count":0,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/1536\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media\/1537"}],"wp:attachment":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media?parent=1536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/categories?post=1536"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/tags?post=1536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}